Raydium Soars as Injective Launches on Solana and SEC Greenlights Tokenized Stocks

Raydium (RAY) has experienced a significant surge of 3.37% in the last 5 hours, driven by fresh catalysts and an existing bullish narrative.

The integration of Injective (INJ) on Solana with Raydium as a day-one launch partner is one such catalyst. This partnership enables INJ trading against SOL and other SPL tokens on Solana via Raydium and related venues, adding swap volume and fees to Raydium's operations.

The SEC has also approved a framework for regulated tokenized US stocks, explicitly citing AMMs like Raydium as beneficiaries. This regulatory green light expands Raydium's addressable market to include real-world equities and reduces perceived regulatory tail risk.

Raydium was already in a strong uptrend driven by Solana DeFi volume and protocol buybacks, with the recent news likely serving as a trigger for fresh marginal buyers. The existing bullish narrative and the risk-on backdrop have contributed to Raydium's current price movement.